Furthermore, our analysis of ERK2 expression within patient-derived cancer and paracancerous tissues showed a substantial elevation in ERK2 levels within breast cancer tissue cells, with the H-score value significantly exceeding that in corresponding adjacent tissues (Fig. 3C). This evidence concerns the gene MAPK1 and breast carcinoma.